BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2011
View Archived Issues
Korean scientists synthesize novel protein kinase inhibitors
Read More
Phase II trial of antisense drug iCo-007 begins in the U.S.
Read More
Public gene expression data used to reposition drugs for new indications
Read More
SRT-1720 has beneficial effects in obesity model
Read More
New genetic variants in multiple sclerosis identified
Read More
Advinus Therapeutics discloses novel glucokinase activators
Read More
New immunosuppressants disclosed by Daiichi Sankyo
Read More
Chinese researchers patent novel anticancer agents
Read More
Pfizer synthesizes novel tyrosine-protein kinase inhibitors
Read More
Australian research team patents novel agents for RSV infection
Read More
Vertex designs novel series of protein kinase inhibitors
Read More
Fresolimumab receives orphan drug designation in the E.U.
Read More
Delcath reports data from phase II trial of its chemosaturation system
Read More
Isconova announces expansion of vaccine collaboration with Genocea
Read More
Cell Therapeutics submits response to questions raised by EMA regarding pixantrone MAA
Read More
Mesoblast performs first lumbar disc procedure in phase II stem cell trial
Read More
Incivek obtains approval in Canada for hepatitis C
Read More
Mayo Clinic obtains IND clearance for ovarian and breast cancer vaccine trials
Read More
First patient enrolled in phase I/II study of Hemispherx's Ampligen in breast cancer
Read More
Symphogen begins phase II trial of Sym-004 in head and neck cancer
Read More
AstraZeneca launches Brilinta in the U.S. for patients with ACS
Read More
Bayer gains FDA fast track designation for Alpharadin
Read More
Nippon Kayaku files for approval of additional dosages and indications for Randa and Lastet in Japan
Read More
BioDelivery Sciences plans commercial launch of Onsolis in Canada
Read More
Cres Pharmaceuticals compound obtains orphan status for primary myelofibrosis
Read More